Patterns of anti-osteoporosis medication use among women at high risk of fracture: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
<h4>Objective</h4>To assess patterns of anti-osteoporosis medication (AOM) use over 3 years among women at high risk of major fracture.<h4>Methods</h4>The GLOW registry follows a cohort of more than 40,000 women aged ≥ 55 from 615 primary care practices in 10 countries. Self-...
Guardado en:
Autores principales: | Stephen Gehlbach, Frederick H Hooven, Allison Wyman, Adolfo Diez-Perez, Jonathan D Adachi, Xuemei Luo, Andrew G Bushmakin, Frederick A Anderson, GLOW Investigators |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/88c1bae99a174d21a8d7bc6c56271aa7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010) -
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009) -
Primary osteoporosis in postmenopausal women
por: Meng-Xia Ji, et al.
Publicado: (2015) -
Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
por: Ciubean AD, et al.
Publicado: (2018) -
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
por: Hartmut H Malluche, et al.
Publicado: (2021)